Press Releases

May 3rd, 2021

TORONTO, May 3, 2021 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, has secured a Health Canada Research Licence for its cannabis product manufacturing and innovation centre in Paris, Ont. The licence allows the Company to conduct human sensory analysis and […]

April 19th, 2021

TORONTO, ON April 19, 2021 — Aleafia Health Inc. (TSX: AH, OTC: ALEAF), a leader in cannabis wellness products and brands, today announced that CEO Geoffrey Benic will present in two virtual investor conferences on April 20th, 2021. OTC Markets Cannabis Investor Conference DATE: Tuesday, April 20th TIME: 11:00 a.m. EDT LINK: REGISTER 2021 Sequire […]

April 16th, 2021

TORONTO – April 16, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2021 first quarter results on May 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EDT. The call will be hosted by […]

April 13th, 2021

TORONTO, April 13, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its trailblazing new cannabis wellness brand Noon & Night. It launches with two new innovative product formats, the first of its kind Omega CBD Soft Gels and Lavender Fizz CBD bath […]

April 7th, 2021

TORONTO, April 7, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its everyday cannabis brand Divvy, tailored to frequent cannabis consumers who are both price and quality conscious. “Led by our experienced growers, Aleafia Health has developed a long track record of […]

March 25th, 2021

233% increase in Q/Q cannabis net revenue $4.3 million positive adjusted EBITDA in Q4 2020 42% and 501% increase in Q/Q medical cannabis and adult-use net revenue, respectively Significant product portfolio expansion with 31 new SKUs launched since October TORONTO – March 25, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or […]

March 16th, 2021

TORONTO, March 16, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that its products are now available to consumers in Saskatchewan. The initial provincial launch includes a broad array of Aleafia Health’s cannabis product portfolio, including sublingual strips, cannabis oils, dried flower, and vape cartridges. […]

March 9th, 2021

TORONTO – March 9, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced bought deal offering (the “Offering”) for a total issuance of 27,390,000 units of the Company (“Units”) at a price per Unit of $0.83 for gross proceeds […]

March 2nd, 2021

TORONTO, March 2, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of THC soft chews under its edibles brand Bogart’s Kitchen. They represent Aleafia Health’s premiere cannabis edible product and the first launch under the Bogart’s Kitchen banner. They have commenced shipping to […]

February 25th, 2021

TORONTO – February 25, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2020 fourth quarter and fiscal year results on March 25, 2021 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will […]

February 17th, 2021

TORONTO – February 17, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has agreed to increase the size of its previously announced “bought deal” offering of units led by Cantor Fitzgerald Canada Corporation as lead underwriter and sole bookrunner, on behalf of a […]

February 16th, 2021

TORONTO, February 16, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced its wholly owned subsidiary Emblem Cannabis Corporation has received a Health Canada Processing Licence (the “Licence”) for its new Distribution Centre (the “DC”). Located minutes from Toronto Pearson International Airport, the DC greatly strengthens the Company’s […]

February 11th, 2021

TORONTO, February 11, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its new Canadian cannabis portfolio Sunday Market. Under the Sunday Market family are four new distinct brands, each tailored to a specific consumer segment and featuring its own roster of cannabis […]

February 2nd, 2021

TORONTO, February 2, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the full repayment in cash of its 8% unsecured convertible debt (the “Convertible Debt”), which matured on February 2, 2021. Emblem Corp., which issued the Convertible Debt on February 2, 2018, was acquired by the Company […]

February 1st, 2021

TORONTO – February 1, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that the board of directors (the “Board”) has appointed Lu Galasso and Carlo Sistilli as independent directors to the Board.  Mr. Galasso will be appointed to the Strategic Planning Committee and Mr. Sistilli […]